KMT2A and neoplasm: Guarnerio J. et al. first described the fusion-circRNAs (f-circRNAs) derived from tumor-associated chromosomal translocations, such as PML-RARα, MLL-AF9, and EWSR1/FLI1, and characterized their oncogenic role in hematological malignancies [20].